Source: iQoncept / Shutterstock
Hepion Pharmaceuticals (NASDAQ:HEPA) just reported results for the first quarter of 2024.
- Hepion Pharmaceuticals reported earnings per share of -56 cents.
- The company did not report any revenue for the quarter.
Article printed from InvestorPlace Media, https://investorplace.com/earning-results/2024/05/hepa-stock-earnings-hepion-pharmaceuticals-for-q1-of-2024/.
©2024 InvestorPlace Media, LLC